Cigna and CVS Health stock prices fell after Trump proposed lowering drug prices by "eliminating middlemen" earlier.

The stock prices of American healthcare companies with pharmacy benefit management businesses fell on Monday, following a plan proposed by President Donald Trump aimed at "eliminating" intermediaries in the pharmaceutical industry to lower drug prices. Cigna dropped 7.2% at one point, CVS Health fell 5%; UnitedHealth dropped 1%.